吉列德科学和美CDC就HIV事先预防(PrEP)药的专利归属首次互撕在公堂!美CDC于2019就起诉吉列德科学没支付PrEP的2个口服药专利费,GILD对此说法坚决予以否认;CDC科学家在新的千禧第一个10年发现,2种抗艾药emtricitabine和tenofovir组合在一起,可高效预防HIV感染;吉列德科学的Truvada和Descovy均含emtricitabine/tenofovir,202...
For patients with HIV who have used long acting cabotegravir as PrEP, INSTI resistance testing should be done before starting ART. If ART is started before the genotype test results are known, then the following regimen is recommended: Boosted darunivir plus either tenofovir alafenamide or tenofo...
研究结果:HIV PrEP队列(n=327)和HIV感染者队列(n=174)细菌性STI的相对风险(RR)均有所降低,包括淋病(RR 0.45,95%CI:0.34～0.65;RR 0.45,95%CI:0.34～0.65)、衣原体(RR 0.12,95%CI:0.05～0.25;RR 0.26,95%CI:0.12～0.57)和梅毒(RR 0.13,95%CI:0.03～0.59;RR 0.23,95%CI:0.04～1.29)。 法国ANRS D...
继2012年在Truvada(舒发泰)被美国FDA批准为暴露前预防(PrEP)用药的2年之后,本周美国CDC的暴露前预防用药指南才姗姗来迟。在此我做个分享下载地址如下:如果百度能显示下载地址。。。http://www.cdc.gov/hiv/pdf/guidelines/PrEPguidelines2014.pdf指南关键部分如下:(我作简要翻译)使用药物:指南推荐使用TDF/FTC 作为性...
研究发现,每天服用固定剂量的替诺福韦和恩曲他滨(即Truvada)可以长期有效地预防HIV感染。美国CDC建议下列哪些高危人群接受暴露前预防(PrEP)的措施()A.男男
CDC says all sexually active patients should be told about HIV PrEPThe CDC on Wednesday recommended that all sexually active adult and adolescent patients be informed about HIV PrEP.Caitlyn StulpinInfectious Disease News
"PrEP is a new approach to HIV prevention that requires continuing collaboration between patients and providers, as effectiveness requires adherence to daily medication and regular medical visits for monitoring, counseling and testing," Smith said. ...
『科普』♀12-19..You can get or transmit HIV only through specific activities. Most commonly, people get or transmit
百度试题 题目下列不是服用 PrEP 期间的监测的是 A.心肺功能B.肾功能C.HIV 感染D.性病相关知识点: 试题来源: 解析 A 反馈 收藏
The agency has been working on updated recommendations for doctors treating these severe cases, which federal datasuggestsare now happening mostly in immunocompromised Hispanic or Black men with advanced HIV. "Even though we're finding it, I guess, comforting or reassuring that the number of case ...